The Latest Breaking News from Abbott

Dr. Josie Tenore and Paul Hinds were introduced by a mutual friend in 2017 and hadn’t been going out long when she laid down the law: He had to get a physical.

What’s behind the $38,398 price tag for a single dose of the drug to treat prostate cancer? A mixture of unrelenting drug price increases and hospital system consolidation.

Lupron, a drug patented half a century ago, treats advanced prostate cancer. It costs a few hundred dollars in the U.K. — so why are U.S. hospitals charging so much more to administer it?

Stocks jumped Monday, but soon hit resistance amid surging Treasury yields. Tesla hit lows on earnings while Netflix jumped.

Abbott Laboratories is building a new infant-formula manufacturing plant after the product shortage of the past year revealed gaps in U.S. production capacity.

Abbott enjoyed a third-quarter beat thanks, in part, to its Covid tests. But those sales are expected to peter out, and ABT stock slumped.

The recall, issued on Oct. 14, includes the brands Similac and Pedialyte Electrolyte Solution

Holley’s mission is to bring awareness to all disabilities with the message, “Our Ability is STRONGER than our dis-Ability.”

Select Similac products are part of a new recall from Abbott Nutrition.

Several months after the US government began investigating an Abbott Laboratories baby-formula plant for its connection to the deaths of at least two infants, the world’s most influential judge of corporate environmental, social and governance practices upgraded the company.

The 65-year-old mega-talent has been criminally underappreciated until now – ‘Isn’t it such a blessing that I could remain relevant after all of these years?’